Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing
Launched by STANFORD UNIVERSITY · Nov 16, 2017
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at different types of dressings that are used to cover surgical wounds after heart surgery. Specifically, it will compare two new types of dressings with a standard one currently used at Stanford Hospital to see which one helps reduce the risk of infections in the area of the chest where surgery is performed. The study will involve patients who are scheduled to undergo heart surgery that requires a sternotomy, which is an incision made in the chest. Participants will be randomly assigned to one of three dressing types, and the researchers will also look at whether the type of dressing affects how often patients need to return to the hospital within 30 days due to infections.
To be eligible for this study, participants need to be adults aged 65 or older who are having certain types of heart surgeries, such as valve surgery or coronary artery bypass grafting (CABG). However, those having heart transplants or facing complicated post-surgery situations will not be included. If you decide to take part in this trial, you can expect to receive one of the dressings and be monitored for any signs of infection during your recovery. Your participation will help researchers understand which dressing works best to keep patients safe and healthy after heart surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants who will undergo cardiac surgery via a sternotomy incision.Inclusion criteria will be patients having surgical valve, CABGs, aortic dissection, myectomy and myotomy, Cox MAZE, Myocardial bridge Un-roofing
- Exclusion Criteria:
- • Patients undergoing heart transplants, Ventricular Assist Device (VAD), with postoperative courses complicated by tamponade, take-backs, and open chest incisions will also be excluded.
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stanford, California, United States
Patients applied
Trial Officials
Jack Boyd, M.D.
Principal Investigator
Cardiovascular Surgeon
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials